Desensitization of highly pre-sensitized dialysis patients waiting for kidney transplantation by Rituximab, IVIG-L and rescue Plasmapheresis THE DRIP STUDY - THE DRIP STUDY

Academisch Medisch Centrum0 个研究点目标入组 12 人待定

适应症niertransplantatie Transplantation

概览

阶段: 3 期
干预措施: 未指定
疾病 / 适应症: niertransplantatie
发起方: Academisch Medisch Centrum
入组人数: 12
状态: 尚未招募
最后更新: 去年

概览研究者入排标准结局指标相似试验

概览

简要总结

暂无简介。

注册库

who.int

开始日期

待定

结束日期

待定

最后更新

去年

研究类型

Interventional

研究者

发起方

Academisch Medisch Centrum

入排标准

入选标准

•\-Patients older than 18 years with end stage renal failure and a current Panel Reactive Antibody level \>\= 80 % who are for more than two years on the waiting list for a cadaveric donor kidney, and included in the Acceptable Mismatch program of Eurotransplant.
•\-Written informed consent

排除标准

•Complete IgA deficiency
•Overhydration
•History of anaphylaxis against blood/plasma products
•Significant cardiac or pulmonary disease, hepatitis C or HIV infection, or malignancy within the last 5 years

结局指标

主要结局

未指定

相似试验

尚未招募

不适用

AMC-DRIPHighly sensitized renal transplant recipients, desensitization, high PRA, kidney transplantation.Hoog gesensibiliseerde niertransplantatie patienten, desensibilisatie, hoge PRA, niertransplantatie

NL-OMON26482Dr. Ajda T. Rowshani; Nephrologist-Clinical ImmunologistAcademic Medical CenterDepartment of Internal Medicine, F4-215PO Box 22700100 DE Amsterdam, The NetherlandsTel: +31-20-5663365 page 58816Fax: +31-20-6914904E-mail:T.Rowshani@AMC.UVA.17

招募中

不适用

Pre-emptive rehabilitation to prevent dialysis-associated morbidityRenal failureUrological and Genital Diseases

ISRCTN89178223Derby Teaching Hospitals NHS Foundation Trust60

尚未招募

不适用

Blood-pressure variability and hypertensive control in patients with renal failure - the potential for smoother and superior control of mean blood-pressure and episodic hypertension through higher-dose dialysis.

ACTRN12614000929606Alfred Health Renal Unit60

进行中（未招募）

不适用

A Study in Renal Predialysis and Dialysis Patients of the Safety, Tolerability, and Immunogenicity of Recombinant Hepatitis B Vaccine Manufactured With a Modified Process - NDProphylactic vaccination against infection with hepatitis B virus in renal predialysis and dialysis patientsMedDRA version: 9.1Level: LLTClassification code 10038474Term: Renal insufficiency

EUCTR2006-003650-20-ITMerck and Co Inc.276

进行中（未招募）

1 期

A Study in Renal Predialysis and Dialysis Patients of the Safety,Tolerability, and Immunogenicity of Recombinant Hepatitis BVaccine Manufactured with a Modified Process - Hepatitis B Vaccine (Recombinant) Dialysis StudyHepatitis BMedDRA version: 8.1Level: LLTClassification code 10019731Term: Hepatitis B

EUCTR2006-003650-20-GBMerck & Co Inc.,276